Company news
Grail, Inc. (NASDAQ:GRAL) news
Every Grail, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
August 31, 2026
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
August 7, 2026
GRAIL Reports Second Quarter 2026 Financial Results
August 5, 2026
GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference
July 30, 2026
GRAIL to Announce Second Quarter 2026 Financial Results
July 29, 2026
Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test t...
July 16, 2026
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection W...
May 31, 2026
GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026
GRAIL to Present at the 2026 Jefferies Global Healthcare Conference
May 21, 2026
GRAIL : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
May 7, 2026
GRAIL Reports First Quarter 2026 Financial Results
May 5, 2026
GRAIL to Present at the BofA Securities 2026 Health Care Conference
April 30, 2026
GRAIL to Announce First Quarter 2026 Financial Results
April 22, 2026
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide
April 7, 2026
Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection
April 1, 2026
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor
March 12, 2026
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
February 24, 2026
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadl...
February 19, 2026
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results
February 16, 2026
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
January 29, 2026
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 1, 2025
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
November 18, 2025
GRAIL Reports Third Quarter 2025 Financial Results
November 12, 2025
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
November 4, 2025
GRAIL to Announce Third Quarter 2025 Financial Results
October 29, 2025
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
October 20, 2025
/U P D A T E -- GRAIL, Inc./
October 18, 2025
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Ad...
October 17, 2025
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia
October 16, 2025
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Co...
September 23, 2025
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
September 10, 2025
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
August 26, 2025
GRAIL Reports Second Quarter 2025 Financial Results
August 12, 2025
GRAIL to Announce Second Quarter 2025 Financial Results
July 29, 2025
GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study
June 18, 2025
GRAIL to Present at Jefferies Global Healthcare Conference 2025
May 21, 2025
GRAIL Reports First Quarter 2025 Financial Results
May 13, 2025
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED)...
May 12, 2025
GRAIL to Announce First Quarter 2025 Financial Results
April 29, 2025
GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
April 22, 2025
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
February 25, 2025
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
February 21, 2025
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
February 20, 2025